FDA Approves Merck's KEYTRUDA® (pembrolizumab) for the Treatment of Adult and Pediatric Patients with Recurrent Locally Advanced or Metastatic Merkel ...
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2ExuOUC
Πέμπτη 20 Δεκεμβρίου 2018
FDA Approves Merck's KEYTRUDA® (pembrolizumab) for the Treatment of Adult and Pediatric Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma, a Rare Form of Skin Cancer | Antibodies | News Channels - PipelineReview.com
FDA Approves Merck's KEYTRUDA® (pembrolizumab) for the Treatment of Adult and Pediatric Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma, a Rare Form of Skin Cancer | Antibodies | News Channels PipelineReview.com
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2ExuOUC
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2ExuOUC
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.